Dr. Robert E. Klenck, MD

Dr. Klenck practices at Pasadena Orthopedics Inc in Pasadena, California.

Dr. Klenck's NPI, 1154411858, was assigned on October 13, 2006. Dr. Klenck graduated from Keck School of Medicine of USC in 1986. Dr. Klenck holds California license G60894.

Dr. Klenck's primary practice is Pasadena Orthopedics Inc, at 959 E Walnut St, Pasadena, CA 91106 in Los Angeles County. The practice phone is (626) 517-0022.

Dr. Klenck's primary practice is Pasadena Orthopedics Inc in Pasadena, California. Dr. Klenck is also affiliated with Huntington Hospital. The medical group on file is Pasadena Orthopedics. Dmand AI also links Dr. Klenck to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klenck practices, 5 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Klenck's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Klenck is board certified in orthopaedic surgery by the National Board of Physicians and Surgeons. Dmand AI has Dr. Klenck's licenses on file in 2 states: California and Florida.

Dmand AI lists arthritis, bursitis, hip replacement, knee replacement, lower back pain, pelvic and hip fracture and tendon and ligament injury among the conditions Dr. Klenck treats.

CMS data shows 41 Medicare services from Dr. Klenck across 2 procedure codes in 2024, all of them office visits, for 40 Medicare patients. Medicare paid $3,600 for them. Every service was in an office.

CMS counts 40 Medicare patients who saw Dr. Klenck in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have arthritis, and 75% have high blood pressure. 33% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Klenck's median patient age at 71, with 63% women.

In 2024, Dr. Klenck wrote 253 Medicare Part D claims for 67 patients. 100% of them were for generic drugs. CMS names the drug for 224 of them, across 6 drugs with 11 or more claims each, at $1,605 in total drug cost. In 2023, CMS named 137 claims across 5 drugs.

Dr. Klenck accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Klenck. Dr. Klenck's most frequent co-author is Soheil Najibi, MD, PhD.

CMS Open Payments shows 59 general payments to Dr. Klenck from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. DePuy Synthes Sales Inc. paid the most, $1,689.

Dr. Klenck graduated from Keck School of Medicine of USC in 1986. Dr. Klenck is a member of AAOS and American Association of Physicians and Surgeons.

Dr. Klenck is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.